The infection fatality rate (IFR) of COVID-19 among non-elderly people in the absence of vaccination or prior infection is important to estimate accurately, since 94% of the global population is younger than 70 years and 86% is younger than 60 years. In systematic searches in SeroTracker and PubMed (protocol: https://osf.io/xvupr), we identified 40 eligible national seroprevalence studies covering 38 countries with pre-vaccination seroprevalence data. For 29 countries (24 high-income, 5 others), publicly available age-stratified COVID-19 death data and age-stratified seroprevalence information were available and were included in the primary analysis.
- The IFRs had a median of 0.035% (interquartile range (IQR) 0.013 – 0.056%) for the 0-59 years old population
- 0.095% (IQR 0.036 – 0.125%,) for the 0-69 years old
- The median IFR was:
- 0.0003% at 0-19 years
- 0.003% at 20-29 years
- 0.011% at 30-39 years
- 0.035% at 40-49 years
- 0.129% at 50-59 years
- 0.501% at 60-69 years
Including data from another 9 countries with imputed age distribution of COVID-19 deaths yielded median IFR of 0.025-0.032% for 0-59 years and 0.063-0.082% for 0-69 years. Meta-regression analyses also suggested global IFR of 0.03% and 0.07%, respectively in these age groups. The current analysis suggests a much lower pre-vaccination IFR in non-elderly populations than previously suggested. Large differences did exist between countries and may reflect differences in comorbidities and other factors. These estimates provide a baseline from which to fathom further IFR declines with the widespread use of vaccination, prior infections, and evolution of new variants.
Highlights *Across 31 systematically identified national seroprevalence studies in the pre-vaccination era, the median infection fatality rate of COVID-19 was estimated to be 0.035% for people aged 0-59 years people and 0.095% for those aged 0-69 years.
*The median IFR was 0.0003% at 0-19 years, 0.003% at 20-29 years, 0.011% at 30-39 years, 0.035% at 40-49 years, 0.129% at 50-59 years, and 0.501% at 60-69 years.
*At a global level, pre-vaccination IFR may have been as low as 0.03% and 0.07% for 0-59 and 0-69 year old people, respectively.
*These IFR estimates in non-elderly populations are lower than previous calculations had suggested.
For more: https://media.mercola.com/ImageServer/Public/2022/October/PDF/mortality-risk-covid-pdf.pdf Excerpt:
- Polls taken in 2020 and 2021 revealed Americans were wildly confused and misinformed about their true risk of dying from COVID
- Based on a new preprint analysis by professor John Ioannidis, there’s no reason for anyone to live in fear anymore, regardless of your age, as your risk of dying from COVID is — and always was — minuscule across the board
- Before the COVID jabs were rolled out:
- if you were 19 or younger, your risk of dying of COVID was 0.0003%; only 3 per 1 million infected with COVID at this age ended up dying
- Between ages 60 and 69, the infection fatality rate was 0.501%, i.e., 1 out of 200 infected died
- Emerging evidence suggests the shots are causing immune deficiency in some people, thereby actually raising their risk of dying from SARS-CoV-2 infection, even with the now-milder strains
- The real-world risk of dying from COVID-19 based on published data from the Irish census bureau and the central statistics office for 2020 and 2021 is as follows:
- for people under 70, the death rate was 0.014%
- under 50 years of age, it was 0.002%, which equates to a 1 in 50,000 risk, or about the same as dying from fire or smoke inhalation
- under 25 years of age, the mortality rate was 0.00018%, or 1 in 500,000 risk of dying from COVID
Despite this reality which was stated early on by those who dared to defy the accepted narrative, Harvard has mandated the new COVID booster, threatening to hold enrollment if students don’t comply. Many places still require masking which has been proven to not only be dangerous, but utterly futile as a new study shows viral aerosols likely spread through the floors and walls. A porous mask doesn’t stand a chance.